Literature DB >> 23335176

Palladium-catalyzed asymmetric allylic alkylation of 3-aryloxindoles with allylidene dipivalate: a useful enol pivalate product.

Barry M Trost1, James T Masters, Aaron C Burns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23335176      PMCID： PMC3825682          DOI： 10.1002/anie.201209783

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  24 in total

1.  Enantioselective Construction of Quaternary Stereocenters.

Authors:  Jens Christoffers; Alexander Mann
Journal:  Angew Chem Int Ed Engl       Date:  2001-12-17       Impact factor: 15.336

2.  The palladium catalyzed asymmetric addition of oxindoles and allenes: an atom-economical versatile method for the construction of chiral indole alkaloids.

Authors:  Barry M Trost; Jia Xie; Joshua D Sieber
Journal:  J Am Chem Soc       Date:  2011-11-30       Impact factor: 15.419

3.  Asymmetric transition-metal-catalyzed allylic alkylations: applications in total synthesis.

Authors:  Barry M Trost; Matthew L Crawley
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

4.  The asymmetric intramolecular Heck reaction in natural product total synthesis.

Authors:  Amy B Dounay; Larry E Overman
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

5.  The atom economy--a search for synthetic efficiency.

Authors:  B M Trost
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

6.  Predicting the stereochemistry of diphenylphosphino benzoic acid (DPPBA)-based palladium-catalyzed asymmetric allylic alkylation reactions: a working model.

Authors:  Barry M Trost; Michelle R Machacek; Aaron Aponick
Journal:  Acc Chem Res       Date:  2006-10       Impact factor: 22.384

7.  Palladium-catalyzed asymmetric benzylation of 3-aryl oxindoles.

Authors:  Barry M Trost; Lara C Czabaniuk
Journal:  J Am Chem Soc       Date:  2010-11-10       Impact factor: 15.419

Review 8.  Function-oriented synthesis, step economy, and drug design.

Authors:  Paul A Wender; Vishal A Verma; Thomas J Paxton; Thomas H Pillow
Journal:  Acc Chem Res       Date:  2007-12-27       Impact factor: 22.384

Review 9.  Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents.

Authors:  Chris V Galliford; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

10.  Asymmetric iminium ion catalysis with a novel bifunctional primary amine thiourea: controlling adjacent quaternary and tertiary stereocenters.

Authors:  Patrizia Galzerano; Giorgio Bencivenni; Fabio Pesciaioli; Andrea Mazzanti; Berardino Giannichi; Letizia Sambri; Giuseppe Bartoli; Paolo Melchiorre
Journal:  Chemistry       Date:  2009-08-10       Impact factor: 5.236
View more
  5 in total

1.  Development of the Regiodivergent Asymmetric Prenylation of 3-Substituted Oxindoles.

Authors:  Barry M Trost; Walter H Chan; Sushant Malhotra
Journal:  Chemistry       Date:  2017-03-06       Impact factor: 5.236

2.  Catalytic Asymmetric Allylic Amination with Isatins, Sulfonamides, Imides, Amines, and N-Heterocycles.

Authors:  Ciarán C Lynch; Kaluvu Balaraman; Christian Wolf
Journal:  Org Lett       Date:  2020-04-07       Impact factor: 6.005

3.  Iridium-Catalyzed Enantioselective Allylic Substitution of Aliphatic Esters with Silyl Ketene Acetals as the Ester Enolates.

Authors:  Xingyu Jiang; John F Hartwig
Journal:  Angew Chem Int Ed Engl       Date:  2017-06-27       Impact factor: 15.336

4.  Catalytic Enantioselective and Diastereoselective Allylic Alkylation with Fluoroenolates: Efficient Access to C3-Fluorinated and All-Carbon Quaternary Oxindoles.

Authors:  Kaluvu Balaraman; Christian Wolf
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-27       Impact factor: 15.336

5.  Catalytic asymmetric synthesis of geminal-dicarboxylates.

Authors:  Nisha Mistry; Stephen P Fletcher
Journal:  Chem Sci       Date:  2018-06-28       Impact factor: 9.825
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.